Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family

Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family

Arenaviral infections often result lethal hemorrhagic fevers, affecting primarily in African and South American regions. To date, there is no FDA-approved licensed vaccine against arenaviruses and treatments have been limited to supportive therapy. Hence, the study was employed to design a highly im...

Full description

Bibliographic Details
Main Authors: Kazi Faizul Azim, Tahera Lasker, Rahima Akter, Mantasha Mahmud Hia, Omar Faruk Bhuiyan, Mahmudul Hasan, Md Nazmul Hossain
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Heliyon
Subjects:
Arenavirus
Hemorrhagic fevers
Nucleoprotein
Recombinant vaccine
Molecular docking
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844021011257

Internet

http://www.sciencedirect.com/science/article/pii/S2405844021011257

Similar Items